Updates are available Correction dated 2023-10-16
Click to view Correction: https://doi.org/10.1007/s13402-023-00890-x
-
Authors
Yang, Yi
Wang, Siqi
Cai, Jiaoyang
Liang, Jianwei
Zhang, Yingwen
Xie, Yangyang
Luo, Fei
Tang, Jingyan
Gao, Yijin
Shen, Shuhong
Feng, Haizhong
Li, Yanxin http://orcid.org/0000-0003-1055-5029
-
Funding
Funding for this research was provided by:
National Key R&D Program of China (2018YFC1313000, 2018YFC1313005)
National Natural Science Foundation of China (81972341, 32271007)
Shanghai Municipal Commission of Science and technology (201409002700, 17411950400)
Program of Shanghai Academic/Technology Research Leader (21XD1403100)
the Shanghai Jiao Tong University Medical Engineering Cross Fund (No. YG2017MS32)
the Pudong New Area Science & Technology Development Fund (PKJ2018-Y47)
State Key Laboratory of Oncogenes and Related Genes (KF2115)
- License Information
-
More Information
Article History
Accepted: 24 October 2022
First Online: 15 December 2022
Change Date: 9 October 2023
Change Type: Update
Change Details: The original version of this article was revised: In Fig. 5f of this article the representative MYCN IHC images of tumor from vehicle-treated mice presented the wrong samples. Fig. 5f has been corrected in the original article. The authors declare that this correction does not affect the description, interpretation, or the original conclusions of the manuscript.
Change Date: 16 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13402-023-00890-x
Declarations
:
: The study was conducted according to the Ethical Principles of Measures for Ethical Review of Biomedical Research Involving Human Beings and the Declaration of Helsinki.
: All patients provided written informed consent prior to participating in any study-specific procedures.
: All authors read and approved the final manuscript.
: The authors declare no conflicts of interest.
